[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100639144":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":31,"responsibleParty":49,"collaborators":20,"id":52,"slug":20,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":20,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":20,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":34,"whyStopped":20,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"interventional arm","EXPERIMENTAL","open label flexible dose",[13],"Drug: methylphenidate hydrochloride (Jornay PM)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","methylphenidate hydrochloride (Jornay PM)","all participants will receive active treatment",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Jay Salpekar, MD","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Neuropsychiatry Study Coordinator","CONTACT","443-923-7612","ertenu@kennedykrieger.org",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Kennedy Krieger Institute","RECRUITING","Baltimore","Maryland","21205","United States",{"type":40,"coordinates":41},"Point",[42,43],-76.61219,39.29038,{"lat":43,"lon":42},[46],{"name":23,"role":28,"phone":47,"phoneExt":20,"email":48},"443-923-7600","salpekar@kennedykrieger.org",{"type":24,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Jay Salpekar, M.D.","MD","100639144",false,"NCT07594652","Medication Treatment of ADHD in Pediatric Epilepsy","USE of JORNAY PM® to TREAT ADHD in PEDIATRIC EPILEPSY","Inclusion Criteria:\n\n* Inclusion criteria:\n\n  * Established diagnosis of epilepsy that requires treatment with anti-seizure medication.\n  * No episodes of seizure clusters or status epilepticus within 30 days prior to entry into the study.\n  * Diagnosis of ADHD with functional impairment.\n  * Good general health as determined by medical history and physical examination, including stable vital signs.\n  * Participant or legal caregiver capable of providing informed consent and fully capable of monitoring the subject's disease process and compliance with treatment.\n\nExclusion Criteria:\n\n* • Previous allergic or hypersensitivity reactions to stimulant medicines including Jornay PM®\n\n  * Active substance abuse or dependence within 30 days of enrollment\n  * Epilepsy that is unstable or with seizure frequency that exceeds four events per month, based on an average over the previous three months\n  * DSM-V diagnosis of psychotic illness or imminent risk of harm to self or others.\n  * Current use of stimulants to treat ADHD\n  * Serious or unstable medical or neurologic conditions such as HIV, liver or kidney disease, cancer or diabetes.\n  * Unstable cardiac illness such as arrythmias or cardiomyopathy.\n  * Participation in a previous experimental drug study within 30 days of baseline visit.\n  * Estimated IQ\\\u003C70 as indicated by clinical assessment to the degree that rating scales may be invalid\n  * Insufficient capacity of caregiver or legal guardian to understand and appropriately consent for study procedures","ALL","6 Years","17 Years",{"count":62,"type":63},25,"ESTIMATED","INTERVENTIONAL",[66],"PHASE4","This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.",[69],"ADHD - Attention Deficit Disorder With Hyperactivity",[71,72],"ADHD","epilepsy","2026-05-15",{"date":75,"type":76},"2026-05-19","ACTUAL",{"date":78,"type":63},"2026-05",{"date":80,"type":63},"2030-12",{"name":5,"class":6},1]